Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT05456256 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Lantern Pharma Inc. |
| Last Updated on CT.gov | November 20, 2025 (Nov 20, 2025) |
As of March 2, 2026: Clinical trial NCT05456256 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Lantern Pharma Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05456256 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05456256 was last updated Nov 20, 2025 (November 20, 2025). HelloStudys verifies this status automatically.